Literature DB >> 17045084

Surgical management of renal cell carcinoma.

Bradley C Leibovich1, Michael L Blute.   

Abstract

Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.

Entities:  

Mesh:

Year:  2006        PMID: 17045084     DOI: 10.1053/j.seminoncol.2006.06.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer.

Authors:  Ganesh V Raj; R Houston Thompson; Bradley C Leibovich; Michael L Blute; Paul Russo; Michael W Kattan
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

2.  Characterization of a new renal cell carcinoma bone metastasis mouse model.

Authors:  Anne Strube; Elizaveta Stepina; Dominik Mumberg; Arne Scholz; Peter Hauff; Sanna-Maria Käkönen
Journal:  Clin Exp Metastasis       Date:  2010-05-05       Impact factor: 5.150

3.  miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.

Authors:  Guang-Jian Lu; Yu-Qian Dong; Qun-Mei Zhang; Wen-Yu Di; Lu-Yang Jiao; Qing-Zu Gao; Chen-Guang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Combined Treatment with Valproic Acid and 5-Aza-2'-Deoxycytidine Synergistically Inhibits Human Clear Cell Renal Cell Carcinoma Growth and Migration.

Authors:  Wenjin Xi; Xu Chen; Jinbo Sun; Wei Wang; Yi Huo; Guoxu Zheng; Jieheng Wu; Yufang Li; Angang Yang; Tao Wang
Journal:  Med Sci Monit       Date:  2018-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.